Inventor · disambiguated record
Ying Hu
Also filed as: HU YING · HU YING JIE
17 granted patents·14 pending applications·48 citations·filing 2009–2025
90Inventor score
Files withREGENERON PHARMA21SHENZHEN NEW IND BIOMEDICAL ENGINEERING CO LTD3GENEVOYAGER WUHAN CO LTD2ALNYLAM PHARMACEUTICALS INC1AVERY DENNISON CORP1
Top patents by PatentIndex Score
31 records- 0197US9795121B2Humanized C3 animalsREGENERON PHARMA·Filed 2015·Granted Oct 24, 2017·18 cites·23 claims
- 0295US10633434B2Anti-C5 antibodiesREGENERON PHARMA·Filed 2017·Granted Apr 28, 2020·20 cites·18 claims
- 0387US10492477B2Humanized C5 animalsREGENERON PHARMA·Filed 2017·Granted Dec 3, 2019·2 cites·26 claims
- 0486US11178860B2Humanized C5 animalsREGENERON PHARMA·Filed 2019·Granted Nov 23, 2021·1 cites·20 claims
- 0584US11492392B2Polynucleotides encoding anti-C5 antibodiesREGENERON PHARMA·Filed 2020·Granted Nov 8, 2022·1 cites·23 claims
- 0683US11479602B2Methods of treating C5-associated diseases comprising administering anti-C5 antibodiesREGENERON PHARMA·Filed 2020·Granted Oct 25, 2022·1 cites·23 claims
- 0781US2024309100A1Anti-Trkb Monoclonal Antibodies And Methods Of UseREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0878US2023174631A1Anti-c5 antibodies and uses thereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0977US2022132818A1Humanized c5 animalsREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1076US11419318B2Genetically modified rat comprising a humanized TRKB locusREGENERON PHARMA·Filed 2018·Granted Aug 23, 2022·1 cites·9 claims
- 1174US2024148774A1Treatment Of Inflammation With Glucocorticoids And Angiopoietin-Like 7 (ANGPTL7) InhibitorsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1272US12037401B2Anti-TrkB monoclonal antibodies and methods of useREGENERON PHARMA·Filed 2021·Granted Jul 16, 2024·0 cites·12 claims
- 1371US12396444B2Mouse comprising a humanized TRKB locusREGENERON PHARMA·Filed 2022·Granted Aug 26, 2025·0 cites·14 claims
- 1471US10524458B2Humanized C3 animalsREGENERON PHARMA·Filed 2018·Granted Jan 7, 2020·0 cites·24 claims
- 1570US11865134B2Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2022·Granted Jan 9, 2024·0 cites·3 claims
- 1670US11066474B2Anti-TrkB monoclonal antibodies and methods of useREGENERON PHARMA·Filed 2018·Granted Jul 20, 2021·0 cites·9 claims
- 1769US9549474B2Cover removal fixtureTHOMSON LICENSING·Filed 2013·Granted Jan 17, 2017·4 cites·15 claims
- 1867US2025129371A1Treatment Of Macular Degeneration With Complement Factor D (CFD) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1961US10988605B2PVC compositions, films, laminates and related methodsAVERY DENNISON CORP·Filed 2018·Granted Apr 27, 2021·0 cites·40 claims
- 2058US2024409943A1iRNA Compositions and Methods for Targeting ANGPTL7ALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2156US11845989B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2020·Granted Dec 19, 2023·0 cites·4 claims
- 2255US12473571B2Expression cassette for expressing gene comprising overlapping open reading frames in insect cell and application thereofGENEVOYAGER WUHAN CO LTD·Filed 2021·Granted Nov 18, 2025·0 cites·20 claims
- 2355US2023383310A1Expression cassette of gene comprising overlapping open reading frames and application thereof in insect cellGENEVOYAGER WUHAN CO LTD·Filed 2021·Application pending·0 cites
- 2454US2025243533A1Method for test item configuration, method for sample analysis and control terminalSHENZHEN NEW IND BIOMEDICAL ENGINEERING CO LTD·Filed 2025·Application pending·0 cites
- 2552US2024216919A1Amplification Plate Assembly and State Detection Method of Amplification Plate AssemblySHENZHEN NEW IND BIOMEDICAL ENGINEERING CO LTD·Filed 2023·Application pending·0 cites
- 2650US2010093624A1Peptide therapeutics that bind vegf and methods of use thereofCOSMIX THERAPEUTICS LLC·Filed 2009·Application pending·0 cites
- 2750US2022089664A1Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) InhibitorsREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 2849US2025244346A1Method and apparatus for displaying experimental state of biological sample, and system for analyzing biological sampleSHENZHEN NEW IND BIOMEDICAL ENGINEERING CO LTD·Filed 2025·Application pending·0 cites
- 2946US10640513B2Compound and composition for detecting phosgene and diethyl chlorophosphateEWHA UNIVERSITY—INDUSTRY COLLABORATION FOUND·Filed 2017·Granted May 5, 2020·0 cites·14 claims
- 3042US2016152717A1Methods for treating dry eye disease by administering an il-6r antagonistREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 3135US2017360013A1Animal model for dry eye and methods of use of such animalsREGENERON PHARMA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ying Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →